Discovery of cMET degrading bispecific antibodies (EpiTACs) for NSCLC and other cMET driven tumors

Written By Jamison Wright

AACR 2025

Download Poster PDF Here
Jamison Wright https://jamisonwright.com
Previous

EpiBiologics Presents First Data on c-Met Degrading Bispecific Antibody
Next

EpiBiologics to Present Data Demonstrating Disease-Selective Extracellular Protein Degradation and Platform Breadth at Upcoming Scientific Meetings